Sandra Tlatli has extensive experience in the pharmaceutical industry, having held various roles primarily focused on strategic account management and business project leadership. At GlaxoSmithKline from October 2012 to March 2013, Sandra contributed to commercial performance analysis and product launches, while also developing internal communication tools. Subsequently, as a Business Project Leader for GSK & ViiV Healthcare, the role involved developing strategies for hospital market analysis and product launches. From October 2014 to January 2017, Sandra served as a Pharmacien Responsable and Pharmacien Coordinateur for commercial projects at GSK, overseeing key initiatives such as the elimination of the pharmaceutical vignette. Prior experience includes research collaboration at Hopital militaire principal d'instruction de Tunis and a position as an assistant in a pharmacy. Currently, Sandra Tlatli is the Director of Key Accounts in the Pharmaceutical Industries at VIDAL Group, showcasing a solid background strengthened by an MBA in Marketing and Management from ESG Paris.
This person is not in the org chart
This person is not in any teams
This person is not in any offices